Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
2015-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2252d7b3a430062bf246f53d2cc345a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8263d58bc7756c76b7713b987aa54918 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e26e3ed1549d76b44efd2dffa8e868 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c06d7f1ccd893dba064a6240885f9ba5 |
publicationDate |
2015-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015112438-A1 |
titleOfInvention |
cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY |
abstract |
Described herein are compositions composed of peptide nucleic acid strands. In some aspects the peptide nucleic acid strands are complementary to at least a portion of another peptide nucleic acid strand that may have one or more gamma substituents, where the ratio of PNA strands is least 1:1. Certain gamma substituents are capable of effecting attachment of a PNA strand to a cell. The disclosure also concerns construction of nanostructure platforms and vaccines and use of the inventive compositions in inhibiting disease states in mammals. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597925-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207418-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300145-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022097151-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3498844-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745446-B2 |
priorityDate |
2014-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |